Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of two wholly owned small molecule drug candidates that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura’s most advanced drug candidate is tipifarnib, a potent, selective and orally bioavailable farnesyl transferase inhibitor currently in a registration-directed trial in patients with recurrent or metastatic HRAS mutant head and neck squamous cell carcinoma. The Company’s pipeline is also highlighted by KO-539, a potent and selective inhibitor of the menin-KMT2A(MLL) protein-protein interaction currently in a Phase 1/2A clinical trial, KOMET-001, in patients with relapsed/refractory acute myeloid leukemia.
Location: United States, Massachusetts, Boston
Total raised: $60M
Investors 5
| Date | Name | Website |
| - | PFM Health... | pfmhealths... |
| - | Foresite C... | foresiteca... |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | Avoro Capi... | avorocapit... |
| - | EcoR1 Capi... | ecor1cap.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.03.2015 | - | $60M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 06.03.2024 | Kura Oncology Reports First Patient Dosed in Trial of KO-280... | - | globenewsw... |
| 30.01.2024 | How an immunological Trojan horse could treat disease | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 14.06.2023 | Kura Oncology Announces Pricing of $100 Million Public Offer... | - | globenewsw... |
| 03.11.2022 | Kura Oncology Announces Financing Transactions with Bristol ... | - | globenewsw... |
| 13.07.2017 | Merck KGaA life sciences reorg will claim 200 jobs; Tesar... | → Merck KGaA is winnowing out 200 jobs over the next five years as it reorganizes its Europe... | endpts.com... |
| 12.03.2015 | Kura Oncology Finds $60M For Cancer Treatments | La Jolla-based Kura Oncology, a biopharmaceuticals startup focusing on treatments for solid tumors a... | socaltech.... |
| 12.03.2015 | Kura Oncology Raises $60M in Funding | Kura Oncology Inc., a La Jolla, California-based biopharmaceutical company focused on treating solid... | finsmes.co... |